semaglutide warnings FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy Semaglutide injection (Wegovy®): Basic information

This infographic breaks down these drugs by active ingredients, brand names and approved uses of popular GLP-1s.

Novo Nordisk India chief says GLP-1 adoption remains low and the market untapped despite patent expiry opening it to generics

Learn how it supports weight reduction and diabetes control correctly.

In the past seven years, the proportion of new, commercial patients who are rejected for a launch brand increased from 37% to 56%, such that more than half of the attempts to initiate a new treatment in 2022 were unfilled the first year

Hims & Hers decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the heart of the ongoing GLP-1 phenomenon.

March 25, 2026